Innovative approaches: Utilizing artificial intelligence for early diagnosis of main neurodegenerative diseases.
4 affiliations
- 1Department of Surgery, School of Medicine, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
- 2Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
- 3Department of Neurosurgery, Neuroendovascular Division, Babol University of Medical Sciences, Mazandaran, Iran.
- 4Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Abstract
Background
By incorporating advanced signal processing and artificial intelligence (AI)/machine learning techniques (MLT) in an automated manner, this system can be trained using extensive patient data, physiological signals, and images. Using state-of-the-art AI models and high-quality clinical data has shown promise in improving prognostic and diagnostic models for neurological diseases. However, it is essential to recognize that AI, machine, and deep-learning algorithms are not universally applicable solutions for all clinical data and inquiries.Methods
This paper offers a comprehensive review of cutting-edge research on the automated diagnosis of major neurological disorders, with a primary focus on the application of AI techniques. An extensive search was conducted in the PubMed and Scopus databases from September 2023 to January 2025; 220 articles were retrieved from the initial search. After eliminating duplicate entries, a total of 105 distinct articles remained. Subsequently, in March 2025, 4 more articles directly pertinent to the topic of interest were identified and included.Results
AI methodologies, particularly Support Vector Machines (SVM) and XGBoost, have demonstrated considerable potential in improving the efficacy of screening tests. AI methods enhance neurological disease diagnosis by integrating advanced diffusion MRI techniques and next-generation PET tracers. Deep learning models, such as convolutional neural networks, improve diagnostic precision and facilitate early detection of neurodegeneration and inflammation in various disorders.Conclusions
Artificial intelligence in combination with conventional methods serves as a valuable resource for the early, precise, and non-invasive identification of neurodegenerative disorders. Additionally, it aids in evaluating treatment efficacy and forecasting the progression of these diseases.
Related
- Harnessing Artificial Intelligence and ChatGPT in Early Detection of Neurodegenerative Disorders: A Transformative Opportunity for Neurology
- The landscape of artificial intelligence in neurodegenerative diseases: a systematic review
- Editorial: Decoding cancer complexity with artificial intelligence and molecular level studies: informatics-driven approaches for therapeutic innovation
- Artificial intelligence literacy and innovative behavior among clinical nurses: the roles of AI self-efficacy and organizational innovation climate
- Differential diagnosis of acid-fast mycobacteria utilizing an artificial intelligence-based approach in histopathological analysis
BibTeX
@article{ebrahimi2026innovative,
title = {{Innovative approaches: Utilizing artificial intelligence for early diagnosis of main neurodegenerative diseases.}},
author = {Hadi Ebrahimi and Ebrahim Hejazian and Zohre Eftekhari},
journal = {Caspian journal of internal medicine},
year = {2026},
month = sep,
doi = {10.22088/cjim.17.3.517},
url = {https://europepmc.org/article/MED/42923513},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Innovative approaches: Utilizing artificial intelligence for early diagnosis of main neurodegenerative diseases.
AU - Hadi Ebrahimi
AU - Ebrahim Hejazian
AU - Zohre Eftekhari
PY - 2026
DA - 2026/09/01
JO - Caspian journal of internal medicine
DO - 10.22088/cjim.17.3.517
UR - https://europepmc.org/article/MED/42923513
AB - Background By incorporating advanced signal processing and artificial intelligence (AI)/machine learning techniques (MLT) in an automated manner, this system can be trained using extensive patient data, physiological signals, and images. Using state-of-the-art AI models and high-quality clinical data has shown promise in improving prognostic and diagnostic models for neurological diseases. However, it is essential to recognize that AI, machine, and deep-learning algorithms are not universally applicable solutions for all clinical data and inquiries.Methods This paper offers a comprehensive review of cutting-edge research on the automated diagnosis of major neurological disorders, with a primary focus on the application of AI techniques. An extensive search was conducted in the PubMed and Scopus databases from September 2023 to January 2025; 220 articles were retrieved from the initial search. After eliminating duplicate entries, a total of 105 distinct articles remained. Subsequently, in March 2025, 4 more articles directly pertinent to the topic of interest were identified and included.Results AI methodologies, particularly Support Vector Machines (SVM) and XGBoost, have demonstrated considerable potential in improving the efficacy of screening tests. AI methods enhance neurological disease diagnosis by integrating advanced diffusion MRI techniques and next-generation PET tracers. Deep learning models, such as convolutional neural networks, improve diagnostic precision and facilitate early detection of neurodegeneration and inflammation in various disorders.Conclusions Artificial intelligence in combination with conventional methods serves as a valuable resource for the early, precise, and non-invasive identification of neurodegenerative disorders. Additionally, it aids in evaluating treatment efficacy and forecasting the progression of these diseases.
SN - 2008-6164
SN - 2008-6172
ER -